Pulse Biosciences Operating Income 2016-2025 | PLSE
Pulse Biosciences operating income from 2016 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Pulse Biosciences Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-56 |
| 2023 | $-44 |
| 2022 | $-58 |
| 2021 | $-63 |
| 2020 | $-50 |
| 2019 | $-48 |
| 2018 | $-38 |
| 2017 | $-26 |
| 2016 | $-10 |
| 2015 | $-4 |
| Pulse Biosciences Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-18 |
| 2024-12-31 | $-20 |
| 2024-09-30 | $-14 |
| 2024-06-30 | $-12 |
| 2024-03-31 | $-11 |
| 2023-12-31 | $-13 |
| 2023-09-30 | $-11 |
| 2023-06-30 | $-10 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-9 |
| 2022-09-30 | $-18 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-17 |
| 2021-12-31 | $-15 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-15 |
| 2021-03-31 | $-19 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-13 |
| 2020-06-30 | $-11 |
| 2020-03-31 | $-12 |
| 2019-12-31 | $-14 |
| 2019-09-30 | $-12 |
| 2019-06-30 | $-12 |
| 2019-03-31 | $-10 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-11 |
| 2018-06-30 | $-9 |
| 2018-03-31 | $-9 |
| 2017-12-31 | $-9 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-1 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.206B | $0.001B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.994B | 86.72 |
| Thermo Fisher Scientific (TMO) | United States | $151.802B | 18.36 |
| Edwards Lifesciences (EW) | United States | $44.969B | 29.49 |
| Alcon (ALC) | Switzerland | $42.113B | 28.46 |
| IDEXX Laboratories (IDXX) | United States | $41.363B | 47.53 |
| DexCom (DXCM) | United States | $34.106B | 52.72 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Mettler-Toledo (MTD) | United States | $24.056B | 28.61 |
| IQVIA Holdings (IQV) | United States | $24.009B | 13.45 |
| Waters (WAT) | United States | $21.101B | 29.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.538B | 0.00 |
| Hologic (HOLX) | United States | $14.197B | 15.43 |
| Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
| Penumbra (PEN) | United States | $10.235B | 80.33 |
| Masimo (MASI) | United States | $8.405B | 31.00 |
| Globus Medical (GMED) | United States | $8.016B | 19.10 |
| Glaukos (GKOS) | United States | $5.426B | 0.00 |
| Teleflex (TFX) | United States | $5.351B | 8.83 |
| TransMedics (TMDX) | United States | $4.350B | 94.57 |
| Integer Holdings (ITGR) | United States | $4.166B | 21.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.333B | 13.89 |
| Nihon Kohden (NHNKY) | Japan | $2.223B | 25.49 |
| Veracyte (VCYT) | United States | $2.093B | 29.36 |
| Elekta AB (EKTAY) | Sweden | $2.075B | 18.66 |
| Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.409B | 0.00 |
| Artivion (AORT) | United States | $1.271B | 119.04 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.987B | 5.25 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.657B | 33.33 |
| RxSight (RXST) | United States | $0.654B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.575B | 8.94 |
| Delcath Systems (DCTH) | United States | $0.564B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.560B | 13.18 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.461B | 12.26 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| NeuroPace (NPCE) | United States | $0.409B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.368B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.253B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.187B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.40 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.71 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |